IBRX (@_IBRX__) header
IBRX (@_IBRX__) profile picture

IBRX

@_IBRX__

Focused on ImmunityBio $IBRX, cancer immunotherapy, and emerging biotech innovations. Connecting investors and biotech enthusiasts. ImmunityBio Stocks

 ImmunityBio
Joined October 2026
  • Tweets11
  • Following117
  • Followers32
Transforming health care with patient access to clinical trials and to Al. Medicines Manhattan Project. Announcing Airstrip. The first step in over a 35 year quest.Every patient can be monitored as an astronaut. The NORAD of healthcare coming soon. Watch the video $IBRX investors
56
2025 was the unveiling of the Bioshield Platform - Anktiya as foundation for killer cells. Now for 2026 unveil. Next element to Bioshield Platform - engineered NK cells to TARGET cancer. The CAR-NK in Phase 2 trials infused w/ Anktiva
3
49
Sepsis induced immunoparalysis. A disease that costs the lives of millions and the largest cost to our hospital system. We can address this and we will. Trials with our IL-15 to begin soon. Unstoppable. Lymphopenia is a disease $IBRX
Dr. Pat Soon-Shiong (@DrPatrick) profile pictureDr. Pat Soon-Shiong
@DrPatrickNov 2
Sepsis induced immunoparalysis. A disease that costs the lives of millions and the largest cost to our hospital system. We can address this and we will. Trials with our IL-15 to begin soon. Unstoppable. Lymphopenia is a disease frontiersin.org/journals/imm…
Image from Dr. Pat Soon-Shiong (@DrPatrick)
Image from Dr. Pat Soon-Shiong (@DrPatrick)
1
34
The speed, scale and sophistication of the heist has left the crypto industry reeling, and renewed questions about the digital-asset markets and whether they will ever fulfill their promise as a viable alternative to the traditional financial system”…… NantX coming soon $IBRX
Image from IBRX (@_IBRX__)
1
28
How do you defend a "no" to access for cÚoMO patients desperately seeking treatment, when the package insert affirms the mechanism that Anktiva activates T cells and NK cells? CUOMO SPECIAL EDITION @PeterPitts provide's the amazing truthfuER? response that there is no reason.
1
109
$IBRX investors is amazing to have a new features and amazing outcome throughout our journey ImmunityBio. Let us know if you want to be part of the journey $ibrx
1
150
We were honored to join the oncology community at #ESMO26 in Madrid, sharing progress in our mission to harness the power of immunotherapy.
Image from IBRX (@_IBRX__)
ImmunityBio, Inc. (@ImmunityBio) profile pictureImmunityBio, Inc.
@ImmunityBioOct 28
We were honored to join the oncology community at #ESMO26 in Madrid, sharing progress in our mission to harness the power of immunotherapy. The energy and collaboration throughout the week reinforced what drives us: advancing innovative treatments with the goal of improving outcomes and quality of life for patients worldwide. Thank you to our team and collaborators who make this work possible.
Image from ImmunityBio, Inc. (@ImmunityBio)
31
Load more